This expanded utility could further enhance their market potential, providing pharmaceutical companies with robust evidence to support the effectiveness and versatility of GLP-1 medications, justifying broader coverage and reimbursement by healthcare payers
What Causes MEN2A
(R-KS) sent a bipartisan letter to the FDA flagging Hims & Hers' ad and accusing the company of misleading patients "by omitting any safety or side effect information when promoting a specific type of weight loss medication." Under federal law and regulations, FDA requires that prescription drug advertisements be truthful, not misleading, and balancedfailure to do so risks FDA enforcement action, including civil monetary penalties, Durbin and Marshall said in the letter
At present, these drugs remain approved primarily for diabetes management and weight control
These are not good enough reasons to demand that consenting, informed adults explain their private medical decisions to make you feel better
Step 2: Preparation The injection area is sanitized, and your provider explains the process